Overexpressed HSP10, high expression of HSP10 combined with low expression of c-PARP and other immunophenotype of HSP10 and c-PARP expression had no impact on astrocytoma WHO grade. This evidence concerns the gene HSPE1 and astrocytoma (excluding glioblastoma).